Name: UMIN ID:
Unique ID issued by UMIN | UMIN000030231 |
---|---|
Receipt number | R000034519 |
Scientific Title | Phase2 study on the validity of initiating treatment during midtrimester for GDM patients |
Date of disclosure of the study information | 2017/12/05 |
Last modified on | 2021/12/07 10:54:00 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/12/03 09:13:16 | ||
2 | Update | 2017/12/03 09:17:14 | Organization1 Address1 Tel1 Email1 Date of disclosure of the study information |
|
3 | Update | 2021/12/07 08:45:14 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
4 | Update | 2021/12/07 10:54:00 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete |